Lymphovascular invasion on explant is associated with presenting tumor characteristics and not direct acting antiviral utilization in hepatitis C candidates undergoing liver transplantation

AIM OF THE STUDY: Utilization of direct acting antiviral (DAA) therapy in candidates with well-compensated hepatitis C virus (HCV) cirrhosis and hepatocellular carcinoma (HCC) accruing end stage liver disease (MELD) exception points is highly variable among transplant centers based on center locatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Muna-Aguon, Paul, Ramanathan, Meera, Choi, Myunghan, Pedersen, Mark, Seetharam, Anil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2019
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935850/
https://www.ncbi.nlm.nih.gov/pubmed/31893238
http://dx.doi.org/10.5114/ceh.2019.88105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935850/
https://www.ncbi.nlm.nih.gov/pubmed/31893238
http://dx.doi.org/10.5114/ceh.2019.88105

Ejemplares similares